Editorial: The relationship between diabetes and cancers and its underlying mechanisms

Front Endocrinol (Lausanne). 2022 Aug 9:13:992569. doi: 10.3389/fendo.2022.992569. eCollection 2022.

Authors

Qiang Huo^{1

2}, Jing Wang³, Nannan Zhang⁴, Long Xie⁵, Heshan Yu⁶, Tao Li¹

Affiliations

¹ Clinical Research Center, Nanjing Jiangbei Hospital, Nanjing, China.
² Center for Translational Medicine, Zibo Central Hospital, Zibo, China.
³ Blood Purification Center, Zibo Central Hospital, Zibo, China.
⁴ Department of Otolaryngology, Zibo Central Hospital, Zibo, China.
⁵ Department of Oncology, Shibo High-Tech Hospital, Zibo, China.
⁶ Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, China.

No abstract available

Keywords: antidiabetic drug; cancer development; cancer risk; diabetes; glucose metabolic disorder; thyroid.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents
Neoplasms* / epidemiology
Neoplasms* / etiology

Substances

Hypoglycemic Agents